30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Research / Technology

Studies suggest that the use of bone morphogenetic protein for spinal fusion has risen sharply over the past decade (5.5% of procedures in 2003 to 28.1% in 2008), increasing costs substantially with no evidence of improved outcomes. (Spine, 2/2012; ScienceDaily, 1/31/12)